These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7518975

  • 21. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 22. Administration of tacrolimus in 50 liver transplantation patients.
    Ye QF, Ruzig MA, Gong NQ.
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
    [Abstract] [Full Text] [Related]

  • 23. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 24. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun 15; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 25. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients.
    Gallon L, Akalin E, Lynch P, Rothberg L, Parker M, Schiano T, Abecassis M, Murphy B.
    Transplantation; 2006 Feb 15; 81(3):463-8. PubMed ID: 16477235
    [Abstract] [Full Text] [Related]

  • 26. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

  • 27. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
    O'Gorman MA, Fivush B, Wise B, Colombani P, Burdick J, Schwarz KB.
    Clin Transplant; 1995 Aug 15; 9(4):312-6. PubMed ID: 7579739
    [Abstract] [Full Text] [Related]

  • 28. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov 15; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 29. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ, Li XY, Shen N, Pang HY, Zhou SL, Guan JQ.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1251-6. PubMed ID: 18713542
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI, Perry PJ, Chen HY, Hunsicker LG.
    Pharmacotherapy; 1998 Jul 20; 18(2):282-7. PubMed ID: 9545147
    [Abstract] [Full Text] [Related]

  • 31. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
    Briggs D, Dudley C, Pattison J, Pfeffer P, Salmela K, Rowe P, Tydén G, European Tacrolimus Renal Rejection Study Group.
    Transplantation; 2003 Jun 27; 75(12):2058-63. PubMed ID: 12829912
    [Abstract] [Full Text] [Related]

  • 32. Distal tubular acidosis induced by FK506.
    Heering P, Ivens K, Aker S, Grabensee B.
    Clin Transplant; 1998 Oct 27; 12(5):465-71. PubMed ID: 9787958
    [Abstract] [Full Text] [Related]

  • 33. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 34. [Acute renal insufficiency caused by burn injury].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Nov 15; 124(9-10):241-5. PubMed ID: 9102856
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for acute renal failure requiring dialysis after liver transplantation.
    Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C.
    Clin Transplant; 1998 Apr 15; 12(2):123-9. PubMed ID: 9575400
    [Abstract] [Full Text] [Related]

  • 36. Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation.
    Faenza S, Santoro A, Mancini E, Pareschi S, Siniscalchi A, Zanzani C, Pinna AD.
    Transplant Proc; 2006 May 15; 38(4):1141-2. PubMed ID: 16757289
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A, Druskis V, Laurinavicius A.
    Clin Nephrol; 2001 Dec 15; 56(6):S27-9. PubMed ID: 11770808
    [Abstract] [Full Text] [Related]

  • 38. Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation.
    López Lago AM, Fernández Villanueva J, García Acuña JM, Paz ES, Vizoso EF, Pérez EV.
    Transplant Proc; 2007 Sep 15; 39(7):2318-9. PubMed ID: 17889176
    [Abstract] [Full Text] [Related]

  • 39. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT, Whitson BA, Kelly RF, D'Cunha J, Dunitz JM, Hertz MI, Shumway SJ.
    J Surg Res; 2013 Sep 15; 184(1):599-604. PubMed ID: 23566442
    [Abstract] [Full Text] [Related]

  • 40. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.
    Am J Kidney Dis; 1999 Jul 15; 34(1):69-84. PubMed ID: 10401019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.